Address
Other Office
450 Newport Center Drive
Suite 600
Newport Beach, CA 92660
United States
Phone
Website
Industry
Business classification
VCID: 32063
Profile
Corporate information
Official name
Versant Ventures Management LLC
Registration country
Investment activity status
Active investor
Company type
Venture capital firm focused on making investments in the healthcare and biotechnology industries.Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Sam Colella | founder | |
|
|
William Link | founder |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Holaira Inc Developer of minimally-invasive products to make breathing easier for patients suffering from obstructive lung diseases |
United States | 12 Feb 2013 | Series C Active |
|
|
|
ROX Medical Inc Developer of devices for treatment of respiratory disease. |
United States | 1 Sep 2012 | Venture |
|
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Apr 2011 1 Jun 2012 |
Series D |
|
|
WaveTec Vision Systems Inc |
United States | 1 Apr 2012 1 May 2011 |
Venture Follow-on investment. Round participant. Active |
|
|
|
Sequent Medical Inc A medical device company that is dedicated to the development of innovative catheter-based devices for neurovascular specialists and their patients |
United States | 1 Mar 2012 1 May 2010 |
Series C |
|
|
Acufocus Inc |
United States | 1 Nov 2011 | N/A Initial investment. Round participant. Active |
|
|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 Sep 2011 | Series D |
|
|
|
NeoVista Inc |
United States | 1 Feb 2011 | Series E Follow-on investment. Round participant. Active |
|
|
|
Okairos AG |
Switzerland | 1 Sep 2010 | Series B |
|
|
|
Cardiac Concepts Inc Now known as Respicardia Inc |
United States | 1 Aug 2010 | Series C |
|
|
|
Immune Design Corp |
United States | 1 Jul 2010 | Series B |
|
|
|
Veracyte Inc |
United States | 11 Jun 2010 | Series B |
|
|
|
Theraclone Sciences Inc |
United States | 1 Mar 2010 | N/A |
|
|
|
Intuity Medical Inc |
United States | 1 Jan 2010 | Series D |
|
|
|
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Nov 2009 | N/A |
|
|
Fluidigm Corp Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. |
United States | 1 Nov 2009 | N/A Follow-on investment. Active |
|
|
|
Ocular Therapeutix Inc A medical device company that is currently engaged in the development of in situ formed hydrogel therapeutic products specifically for ophthalmology. |
United States | 1 Jun 2009 | Series C Initial investment. Round participant. Active |